Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC)

Agarwal, Neeraj; Alva, Ajjai; Bamias, Aristotelis; Baniel, Jack; Bellmunt, Joaquim; Berthold, Dominik R.; Bowles, Daniel W.; Cerbone, Linda; Chowdhury, Simon; Crabb, Simon J.; Daugaard, Gedske; De Giorgi, Ugo; Galsky, Matthew D.; Giardiello, Daniele; Golshayan, Ali-Reza; Harshman, Lauren C.; Ladoire, Sylvain; Lo Vullo, Salvatore; Mariani, Luigi; Milowsky, Matthew I.; Morales-Barrera, Rafael; Necchi, Andrea; Niegisch, Gunter; Pal, Sumanta K.; Powles, Thomas; Rosenberg, Jonathan E.; Sonpavde, Guru; Sridhar, Srikala S.; Srinivas, Sandy; Sternberg, Cora N.; Theodore, Christine; Vaishampayan, Ulka N.; Wong, Yu-Ning; Yu, Evan Y.

Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC)

Abstract

The available prognostic models for overall survival (OS) in patients with metastatic urothelial carcinoma (UC) have been derived from clinical trial populations of cisplatin-treated patients

Similar works

Full text

Open in the Core reader

Download PDF

Available Versions

Carolina Digital Repository

cdr.lib.unc.edu:6108vg98z

Last time updated on 23/04/2020